These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9739917)

  • 21. [Excipients and new topical forms in dermatology].
    Delattre L
    J Pharm Belg; 1993; 48(4):261-9. PubMed ID: 8410631
    [No Abstract]   [Full Text] [Related]  

  • 22. [Methods and models for percutaneous absorption studies of organophosphates].
    Boudry I; Trescos Y; Vallet V; Cruz C; Lallement G
    Pathol Biol (Paris); 2008 Jul; 56(5):292-9. PubMed ID: 18191343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reply: hyaluronic acid: a unique topical vehicle for the localized delivery of drugs to the skin.
    Chandrashekar L
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1348-9. PubMed ID: 17062068
    [No Abstract]   [Full Text] [Related]  

  • 24. Choosing topical corticosteroids.
    Ference JD; Last AR
    Am Fam Physician; 2009 Jan; 79(2):135-40. PubMed ID: 19178066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Special characteristics of topical treatment in childhood].
    Werfel S; Boeck K; Abeck D; Ring J
    Hautarzt; 1998 Mar; 49(3):170-5. PubMed ID: 9565783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prescribe topical treatments for psoriasis].
    Lorette G; Fontès V
    Rev Prat; 2004 Jan; 54(1):40-2. PubMed ID: 15049598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel foam vehicle for delivery of topical corticosteroids.
    Huang X; Tanojo H; Lenn J; Deng CH; Krochmal L
    J Am Acad Dermatol; 2005 Jul; 53(1 Suppl 1):S26-38. PubMed ID: 15968261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safe and effective application of topical treatments to the skin.
    Lawton S
    Nurs Stand; 2013 Jun 19-25; 27(42):49-56; quiz 58, 60. PubMed ID: 23930532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancement of topical delivery of drugs via direct penetration by reducing blood flow rate in skin.
    Higaki K; Nakayama K; Suyama T; Amnuaikit C; Ogawara K; Kimura T
    Int J Pharm; 2005 Jan; 288(2):227-33. PubMed ID: 15620862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Special requirements for topical therapy in infants].
    Wohlrab J
    MMW Fortschr Med; 2008 Jun; 150(25):36-7. PubMed ID: 18705053
    [No Abstract]   [Full Text] [Related]  

  • 31. Vehicle effect on topical drug delivery. II. Concurrent skin transport of drugs and vehicle components.
    Møllgaard B; Hoelgaard A
    Acta Pharm Suec; 1983; 20(6):443-50. PubMed ID: 6675423
    [No Abstract]   [Full Text] [Related]  

  • 32. Research Techniques Made Simple: Drug Delivery Techniques, Part 1: Concepts in Transepidermal Penetration and Absorption.
    Schmieder S; Patel P; Krishnamurthy K
    J Invest Dermatol; 2015 Nov; 135(11):1-5. PubMed ID: 26548480
    [No Abstract]   [Full Text] [Related]  

  • 33. Dermatologic vehicles.
    Ricciatti-Sibbald D; Sibbald RG
    Clin Dermatol; 1989; 7(3):11-24. PubMed ID: 2680013
    [No Abstract]   [Full Text] [Related]  

  • 34. [Topical corticosteroids in dermatology--advantages and side effects].
    Wojas-Pelc A; Setkowicz M; Bogdaszewska-Czabanowska J
    Przegl Lek; 2002; 59(3):170-4. PubMed ID: 12184032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Percutaneous penetration of drugs--application in physical therapy].
    Clarys P; Barel A; Taeymans J
    Sportverletz Sportschaden; 1997 Dec; 11(4):XIX-XXIII. PubMed ID: 9491473
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of urea on the penetration of prednisolone into the human skin].
    Wohlrab W
    Dermatol Monatsschr; 1986; 172(9):523-7. PubMed ID: 3792595
    [No Abstract]   [Full Text] [Related]  

  • 37. [Dermatologic corticosteroid therapy up-date. Corticosteroid administration in dermatology].
    Crespi HG
    Actas Dermosifiliogr; 1981; 72(3-4):101-10. PubMed ID: 7032244
    [No Abstract]   [Full Text] [Related]  

  • 38. Adherence to topical hydrocortisone 17-butyrate 0.1% in different vehicles in adults with atopic dermatitis.
    Wilson R; Camacho F; Clark AR; Young T; Inabinet R; Yentzer BA; Feldman SR
    J Am Acad Dermatol; 2009 Jan; 60(1):166-8. PubMed ID: 19103374
    [No Abstract]   [Full Text] [Related]  

  • 39. Vehicle effect on topical drug delivery. I. Influence of glycols and drug concentration on skin transport.
    Møllgaard B; Hoelgaard A
    Acta Pharm Suec; 1983; 20(6):433-42. PubMed ID: 6675422
    [No Abstract]   [Full Text] [Related]  

  • 40. Nanostructured novel carrier for topical application.
    Guglielmini G
    Clin Dermatol; 2008; 26(4):341-6. PubMed ID: 18691513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.